App-Quantinova.ai

Multicentre evaluation of the novolimus-eluting, fully bioresorbable coronary scaffold: two-year clinical and longer-term imaging endpoints

Abizaid A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rapacan

Twelve-month clinical results following bioresorbable vascular scaffold implantation in STEMI patients: insights from the multicentre Italian ABSORB registry

Ielasi A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: a single-centre experience

Karanasos A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Impact of side branch remodelling in coronary bifurcation lesions on clinical the outcome of provisional stenting

Murasato Y - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Treatment of bifurcation lesions with a thin-strut DES with bioresorbable polymer: clinical outcomes of the CENTURY II trial

Merkely B - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Myocardial infarction rates in bifurcation lesions: are they still elevated after the use of contemporary, highly deliverable drug-eluting stents with novel, flexible designs?

Van Der Heijden L.C - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

Bifurcation stenting failure rates determined from the CVPath Institute Autopsy Registry on BMS and 1st- and 2nd-generation DES

Sanchez O - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Immediate results and one-year follow-up of patients with bifurcation coronary lesions treated with everolimus-eluting bioabsorbable scaffold

Suarez De Lezo J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Regular drug-eluting stent versus dedicated bifurcation sirolimus-eluting stent in the coronary bifurcation treatment: the randomised, multicentre, open-label, controlled POLBOS II trial

Gil R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Risk of scaffold thrombosis after bioresorbable vascular scaffold implantation

Komocsi A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparison of predictors of stent thrombosis between 1st-generation and 2nd-generation drug-eluting stents after primary percutaneous coronary intervention

Cho Y-K - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Predictive factors of one-year stent thrombosis in patients with STEMI treated with titanium-nitro-oxide-coated stent implantation: insights from TITAN-AMI study

J A Gomez - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Clinical parameters do not predict thrombosis after implantation of bioresorbable vascular scaffolds, but introduction of a specific implantation strategy is associated with a significant reduction in its incidence

Cuculi F - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

The comparison between plain old balloon angioplasty vs. stent implantation for stent thrombosis: the New Tokyo registry

Yabushita H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Real-world incidence of early definite stent thrombosis after primary PCI in bivalirudin-treated STEMI patients

Grimfjard P - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Consistent reduction in stent thrombosis risk at 5 years with a zotarolimus-eluting stent versus a sirolimus-eluting stent in men and women

Ten Haaf M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Incidence, predictors and correlates of stent thrombosis following drug-eluting stent implantation up to 12 years in daily practice

Costa R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Stent thrombosis in 2,424 Middle Eastern patients undergoing PCI for acute and stable coronary syndromes is associated with low mortality; the first Jordanian PCI registry (JoPCR1)

Hammoudeh A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence and clinical features of early stent thrombosis in the era of new P2Y12 inhibitors (PLATIS-2)

Asher E - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Intra-thrombus delivery of thrombolytics before thrombectomy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DISSOLUTION randomised trial

Polacco M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Abciximab

Filters

7277 Abstracts